Login

Glaxosmithkline Pharmaceuticals Ltd.

₹2763.6

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Glaxosmithkline Pharmaceuticals Ltd.

Add Alert
Add Watchlist

₹2763.6

₹2763.6

13.1 (0.48%) - 14 Oct 2025 04:20 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 46,817 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 49.70
P/B Ratio 24.02
Enterprise Value -
ROE % 48.92
RSI Value 50.33
EMA 50 2817.04
EMA 200 2790.66
Market Cap. ₹ 46,817 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 49.27
P/B Ratio 23.99
Enterprise Value -
ROE % 49.43
RSI Value 50.33
EMA 50 2817.04
EMA 200 2790.66
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.